
Cartesian Therapeutics
Cartesian Therapeutics: A clinical-stage biopharma firm innovating cell and gene therapies for cancer and autoimmune diseases.
- 38
- Private company
- Frederick, MD, USUnited States
Cartesian Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel cell and gene immunotherapies to treat cancer and autoimmune diseases. The company aims to revolutionize treatment options through innovative therapies that harness the body's immune system to combat these serious health conditions.
Cartesian Therapeutics has achieved significant milestones in advancing its therapies through clinical trials, demonstrating promising results in both safety and efficacy. The company's pioneering approach has attracted attention from leading investors and experts in the biopharmaceutical industry.
M & A Snapshot
Open M & ASimilar Companies
Bioheng

Emulate

Inspirna

Cartography Biosciences
cartography.bio

Ernexa Therapeutics
eternatx.com

Celsius Therapeutics
celsiustx.com

Cellerant Therapeutics

Vitro Biopharma
vitrobiopharma.com

ImmPACT Bio
immpact-bio.com

Jupiter Therapeutics
jupitertx.com

Orca Bio
orcabio.com

Carisma Therapeutics
carismatx.com

JURA Bio
jurabio.com
Artielle ImmunoTherapeutics

LTZ Therapeutics

AffyImmune Therapeutics
affyimmune.com

Century Therapeutics
centurytx.com

Cello Therapeutics
cellothera.com

Aleta Biotherapeutics
aletabio.com

CarthroniX
carthronix.com
Quick Facts
Who are Cartesian Therapeutics' competitors?
Companies similar to Cartesian Therapeutics include Bioheng, Emulate, Inspirna and Cartography Biosciences.
When was Cartesian Therapeutics founded?
Cartesian Therapeutics was founded in 2016.
Where is Cartesian Therapeutics' headquarters located?
Cartesian Therapeutics' headquarters is located in Frederick, MD, US.
When was Cartesian Therapeutics' last funding round?
Cartesian Therapeutics' most recent funding round was for $2M (USD) in May 2021.
How much disclosed funding has Cartesian Therapeutics raised?
As of May 4, 2021, Cartesian Therapeutics has disclosed funding of $2M (USD). Undisclosed round amounts are excluded.
How many employees does Cartesian Therapeutics have?
Cartesian Therapeutics has 38 employees as of Feb 4, 2024.
Classification
- Industry
- Ownership
- Technology
- Geographic Exposure
- Customer
- Main Product
- Tags
- Also Known As
- Cartesian Therapeutics, Inc.
- SELECTA BIOSCIENCES INC
- Headquarters
- 7495 New Horizon Way
- Frederick, MD, 21703
- US
- Ticker
- RNAC
- SEC CIK
- 0001453687
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 541000Professional, Scientific, and Technical Services
- 541700Scientific Research and Development Services
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- SIC
- 8700Engineering, Accounting, Research, Management, And Related Services
- 8730Research, Development, And Testing Services
- 8731Commercial Physical and Biological Research
- Industry
- —Biotechnology Companies
- —Medical Organizations
Show 5 more industry codes
- NAICS
- 620000Health Care and Social Assistance
- SIC
- 8000Health Services
- 8040Offices And Clinics Of Other Health Practitioners
- 2834Pharmaceutical Preparations
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified